Influence of talc dose on extrapleural talc dissemination after talc pleurodesis.
This study was designed to ascertain, in a rabbit model, extrapleural talc deposition and the related inflammatory response after talc slurry pleurodesis with two clinical doses, 200 and 50 mg/kg. Histopathologic evaluations revealed that whereas numerous rabbits receiving a high dose had talc in the ipsilateral (70%) and contralateral (55%) lung, mediastinum (90%), pericardium (30%), and liver (25%), a small number of animals treated with a low dose showed talc in the ipsilateral lung (10%) and mediastinum (20%) and none in the contralateral lung, pericardium, or liver. Hematologic and immunocytochemical analyses showed that a systemic inflammatory response develops shortly after pleurodesis with a high talc dose involving massive accumulation of neutrophils and macrophages in lung tissue. Zymography also revealed that the pulmonary expression of matrix metalloproteinases 2 and 9 was up-regulated in both lungs in a dose-dependent manner soon after talc instillation. Furthermore, microscopic examination of lung specimens revealed that the higher the dose of talc, the greater the development of both fibrotic visceral pleural thickening and foreign-body granulomas. These findings show pleurodesis with a high talc dose to be associated with an increased risk of extrapleural talc deposition, which may originate undesirable acute and chronic inflammatory responses.
Montes
Juan F
JF
Departament deBiologia Cel.lular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
Ferrer
Jaume
J
Villarino
Maria A
MA
Baeza
Bernat
B
Crespo
Marta
M
Garcia-Valero
Jose
J
D000208:Acute Disease; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D008297:Male; D008480:Mediastinitis / Q000139:chemically induced* / Q000473:pathology; D010493:Pericarditis / Q000139:chemically induced* / Q000473:pathology; D010998:Pleurisy / Q000139:chemically induced* / Q000473:pathology; D018700:Pleurodesis / Q000009:adverse effects*; D011014:Pneumonia / Q000139:chemically induced* / Q000473:pathology; D011817:Rabbits; D013627:Talc / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D013997:Time Factors
D013627:Talc